HOLVITA LIQUID COLOSTRUM PILOT STUDY

The double blinded, cross-over clinical study to determine the value of the
cold filtered liquid colostrum holvita tm to chronically ill people with hep
c has started.

The study will determine the potential value of holvita tm liquid colostrum
on patients with hepatitis c related liver cirrhosis and will look at the
effect of this colostrum on
viral load, the blood picture and quality of life.
Lead Investigator is Professor Graham Foster, Professor of Hepatology at Barts and The London and Queen Marys University of London.

The evaluation of this pilot study will take place throughout January 2012
and the results will be published in first quarter of 2012.